These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 302503)
21. [Actol in the treatment of rheumatic diseases]. Furmaniuk M; Zimmermann-Górska I Reumatologia; 1974; 12(1):91-4. PubMed ID: 4546222 [No Abstract] [Full Text] [Related]
22. [Contribution of an anti-inflammatory agent in pedodontics]. Justin J; Blocquel H; Baudin M Lille Med; 1980; 25(7):390-7. PubMed ID: 6448940 [No Abstract] [Full Text] [Related]
23. [Niflumic acid combined with gastroprotective agents in rheumatic pathology]. Serni U; Frosecchi M Reumatismo; 1974; 26(2):109-28. PubMed ID: 4282512 [No Abstract] [Full Text] [Related]
24. Potentiation of Donalgin in the treatment of postinjection and postinfusion phlebitis. Horváth I; Illés T Ther Hung; 1980; 28(4):171-5. PubMed ID: 7209850 [No Abstract] [Full Text] [Related]
25. Niflumic acid in the management of rheumatoid and osteoarthritis. Tilve GH; Lengade JK; Bavadekar AV; Nair KG J Postgrad Med; 1976 Jul; 22(3):124-9. PubMed ID: 1032826 [No Abstract] [Full Text] [Related]
27. [Arthro-Menthoneurin Gel in the treatment of locomotor system diseases]. Steuber U MMW Munch Med Wochenschr; 1976 Oct; 118(44):1433-4. PubMed ID: 825754 [No Abstract] [Full Text] [Related]
29. [Early clinical experiments with a new synthetic anti-inflammatory agent]. Annoni G Clin Ter; 1969 Jan; 48(1):9-51. PubMed ID: 5311536 [No Abstract] [Full Text] [Related]
30. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L]. Traissac L; Roche JC Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941 [No Abstract] [Full Text] [Related]
31. [Effect of niflumic acid on chronic rheumatoid arthritis]. Shichikawa K; Onoda T Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616 [No Abstract] [Full Text] [Related]
32. [Review of the utilization of a new anti-inflammatory agent: influmic acid (UP 83)]. Verhaeghe A; Lesage R; Delcambre B; Catanzariti L Lille Med; 1967 Dec; 12(10):Suppl:1298+. PubMed ID: 5307795 [No Abstract] [Full Text] [Related]
33. [Value of metiazinic acid in the treatment of rheumatismal diseases]. Jacquot F; Gras JP Rhumatologie; 1970 Sep; 22(7):265-70. PubMed ID: 4252010 [No Abstract] [Full Text] [Related]
34. Proglumetacin (protacine): a promising new treatment of the rheumatic joint. Rivera IC Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477 [TBL] [Abstract][Full Text] [Related]
36. [The long term treatment of rheumatoid arthritis with niflumic acid or indometazin in double blind controlled trial (author's transl)]. Rejholec V Med Klin; 1976 Jul; 71():1188-91. PubMed ID: 822265 [TBL] [Abstract][Full Text] [Related]
37. [A.N.P. 3260 in rheumatology]. Vignon G; Falconnet M; Cibert M Rev Lyon Med; 1967 Oct; 16(15):627-31. PubMed ID: 5311741 [No Abstract] [Full Text] [Related]
38. [Role of new anti-inflammatory agents in rheumatologic practice]. Boutelier D Therapeutique; 1969 Dec; 45(10):1033-5. PubMed ID: 5311447 [No Abstract] [Full Text] [Related]
39. [Multicenter study of the anti-inflammatory and analgesic effects of niflumic acid with antibiotics, used preoperatively in dentistry]. Missika P; Ouvrard ; Coudert ; De Mello ; Duran ; Durivaux ; Gass ; Hirigoyen ; Jeandot ; Terrestri Inf Dent; 1990 May; 72(22):1907-10. PubMed ID: 2202676 [No Abstract] [Full Text] [Related]